Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dong-Dong Tian
Elevated Serum Level of Angiopoietin-2 as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Association of VDR-FokI and VDBP-Thr420Lys Polymorphisms With Cervical Spondylotic Myelopathy: A Case-Control Study in the Population of China
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Related publications
Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy
Respiratory Research
Pulmonary
Respiratory Medicine
Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients
Cancer Research
Cancer Research
Oncology
SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
A Lower Level of Forced Expiratory Volume in One Second Predicts the Poor Prognosis of Small Cell Lung Cancer
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer
Oncotarget
Oncology
Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis
Frontiers in Oncology
Cancer Research
Oncology
